Trials / Completed
CompletedNCT00209937
A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia
A Prospective Randomised Double-Blind Parallel-Group Placebo-Controlled Active-Reference Study of Gaboxadol in Primary Insomnia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 675 (planned)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy safety and tolerability of gaboxadol in primary insomnia
Detailed description
To compare the hypnotic efficacy and safety of different dose levels of gaboxadol with placebo in non-elderly patients with primary insomnia over two weeks of treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gaboxadol |
Timeline
- Start date
- 2003-01-01
- Completion
- 2004-06-01
- First posted
- 2005-09-21
- Last updated
- 2007-03-30
Source: ClinicalTrials.gov record NCT00209937. Inclusion in this directory is not an endorsement.